Acquisitions (Details) - USD ($) $ in Thousands |
1 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Aug. 31, 2025 |
Jul. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Mar. 31, 2025 |
|
| Business Combination [Line Items] | ||||||
| Loss on disposal of a business | $ 0 | $ 4,502 | ||||
| Disposal Group, Disposed of by Sale, Not Discontinued Operations | Exscientia GmbH | ||||||
| Business Combination [Line Items] | ||||||
| Loss on disposal of a business | $ 4,500 | |||||
| Alpha Biotechnology GmbH (Alpha) | ||||||
| Business Combination [Line Items] | ||||||
| Equity method investment ownership percentage | 49.00% | |||||
| Equity method investments | $ 4,400 | |||||
| RE Ventures I | ||||||
| Business Combination [Line Items] | ||||||
| Interest acquired | 100.00% | |||||
| Asset acquisition, consideration transferred | $ 20,200 | |||||
| Payments to acquire IPR&D | $ 2,400 | |||||
| X | ||||||||||
- Definition Asset Acquisition, Equity Ownership, Percentage No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|